Mometasone furoate in the management of asthma: a review

Mometasone furoate in the management of asthma: a review

Ricardo A Tan1, Jonathan Corren21California Allergy and Asthma Medical Group, Los Angeles, CA; 2Allergy Research Foundation, Los Angeles, CA, USAAbstract: Inhaled corticosteroids (ICS) have proven to be the most effective and essential therapy for the treatment of bronchial asthma. The 2007 National...

Full description

Bibliographic Details
Main Authors:	Ricardo A Tan, Jonathan Corren
Format:	Article
Language:	English
Published:	Dove Medical Press 2008-09-01
Series:	Therapeutics and Clinical Risk Management
Online Access:	http://www.dovepress.com/mometasone-furoate-in-the-management-of-asthma-a-review-a2269

Similar Items

Efficacy and safety of mometasone furoate/formoterol combination in patients with bronchial asthma
by: A. V. Emelyanov
Published: (2015-12-01)

Efficacy and safety of medium and high doses of mometasone furoate/formoterol (MF/F) combination treatment in subjects with severe persistent asthma
by: Weinstein Steven F, et al.
Published: (2010-12-01)

Efficacy of Mometasone Furoate and Fluticasone Furoate on Persistent Allergic Rhinoconjunctivitis
by: W. Hamizan Aneeza M.S., et al.
Published: (2013-09-01)

Development of semisolid pharmaceutical forms with mometasone furoate
by: Rédai Emőke Margit, et al.
Published: (2023-12-01)

The efficacy of mometasone furoate for children with asthma: a meta-analysis of randomized controlled trials
by: Yanling Song, et al.
Published: (2020-02-01)

Effectiveness of 0.1% mometasone furoate under hydrocolloid dressing versus 0.1% mometasone furoate in patients with lichen simplex chronicus
by: Hiu Lai Lo, et al.
Published: (2023-08-01)

Dose-dependent anti-inflammatory effect of inhaled mometasone furoate/formoterol in subjects with asthma.
by: Nolte, H, et al.
Published: (2013)

Effect of mometasone furoate/formoterol combination therapy on nocturnal awakenings in subjects with persistent asthma
by: Pearlman David, et al.
Published: (2011-11-01)

Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease
by: Kosoglou T, et al.
Published: (2013-03-01)

Nasal Absorption Enhancement of Mometasone Furoate Nanocrystal Dispersions
by: Masuda S, et al.
Published: (2023-10-01)

Mometasone furoate is not superior to saline for chronic rhinitis in the elderly
by: Victor Carvalho, et al.
Published: (2019-10-01)

Development of simple and fast UV-method for the quantitative determination of mometasone furoate in a large number of metered doses of an aqueous nasal spray of mometasone furoate
by: Mykhaylo Levin, et al.
Published: (2019-11-01)

EFFECTIVENESS OF MOMETASONE FUROATE IN TREATMENT OF PALATINE TONSIL HYPERTROPHY IN CHILDREN
by: E.V. Nosulya, et al.
Published: (2009-01-01)

EFFECTIVENESS OF MOMETASONE FUROATE IN TREATMENT OF PALATINE TONSIL HYPERTROPHY IN CHILDREN
by: E.V. Nosulya, et al.
Published: (2009-05-01)

A Patient Preference Study that Evaluated Fluticasone Furoate and Mometasone Furoate Nasal Sprays for Allergic Rhinitis
by: Anahi Yanez M.D., et al.
Published: (2016-10-01)

Efficacy and Safety Evaluation of Mometasone Furoate in Treating Ocular Inflammation
by: Nayara Almeida Lage, et al.
Published: (2023-01-01)

Efficacy of mometasone furoate nasal spray in the treatment of acute rhinosinusitis
by: Sandeep Shrestha, et al.
Published: (2023-01-01)

Comparison of montelukast and mometasone furoate in the prevention of recurrent nasal polyps
by: Erkan Vuralkan, et al.
Published: (2012-02-01)

Assessment of Patient Attitudes About Mometasone Furoate Nasal Spray
by: Leonard M. Fromer, et al.
Published: (2008-01-01)

Mometasone furoate and fluticasone furoate are equally effective in restoring nasal epithelial barrier dysfunction in allergic rhinitis
by: Maria Doulaptsi, et al.
Published: (2021-09-01)

Suppression of cytokine release by fluticasone furoate vs. mometasone furoate in human nasal tissue ex-vivo.
by: Nan Zhang, et al.
Published: (2014-01-01)

Effect of intranasal mometasone furoate administered in children with coexisting allergic rhinitis and asthma towards asthma attacks and lung function
by: Ellen P. Gandaputra, et al.
Published: (2009-12-01)

Mometasone furoate in the treatment of allergic rhinitis: a complex therapeutic effect
by: R. S. Fassakhov, et al.
Published: (2021-09-01)

Influence of apoptosis inhibitors on response to mometasone furoate in patients with RSCcPN
by: Ivna Mota Passos, et al.
Published: (2022-11-01)

New Vehiculation Systems of Mometasone Furoate for the Treatment of Inflammatory Skin Diseases
by: Raquel Taléns-Visconti, et al.
Published: (2022-11-01)

One-year treatment with mometasone furoate in chronic obstructive pulmonary disease
by: Abbate Eduardo H, et al.
Published: (2008-11-01)

Efficacy and onset of action of mometasone furoate/formoterol and fluticasone propionate/salmeterol combination treatment in subjects with persistent asthma
by: Bernstein David I, et al.
Published: (2011-12-01)

Mometasone Furoate in Non-Allergic Rhinitis: A Real-Life Italian Study
by: Angela Rizzi, et al.
Published: (2022-07-01)

Multi-Gram Scale Synthesis and Characterization of Mometasone Furoate EP Impurity C
by: Riccardo Ronchetti, et al.
Published: (2023-11-01)

Developing Biodegradable Nanoparticles Loaded with Mometasone Furoate for Potential Nasal Drug Delivery
by: Jumana Far, et al.
Published: (2020-03-01)

Mometasone Furoate Improves Nasal and Ocular Symptoms of Seasonal Allergic Rhinitis in Adolescents
by: Robert Anolik M.D., et al.
Published: (2010-01-01)

Evaluation of Efficacy of Nasal Sprays Containing Mometasone Furoate and Azelastine Hydrochloride in the Management of Allergic Rhinitis
by: Kemal Görür, et al.
Published: (2002-03-01)

Non-inferiority efficacy comparison of mometasone furoate/formoterol versus fluticasone propionate/salmeterol combination therapies in subjects with persistent asthma
by: Bernstein David I, et al.
Published: (2010-12-01)

Lung function improvements following inhaled indacaterol/glycopyrronium/mometasone furoate are independent of dosing time in asthma patients: a randomised trial
by: Jutta Beier, et al.
Published: (2021-04-01)

Effect of topical drugs on the local concentrations of IL-5 and mometasone furoate in chronic polypous rhinosinusitis
by: M. A. Aflitonov, et al.
Published: (2024-01-01)

Combined therapy in vulvar lichen sclerosus: does topical tretinoin improve the efficacy of mometasone furoate?
by: Alessandro Borghi, et al.
Published: (2017-08-01)

Development, stability and in vitro permeation studies of gels containing mometasone furoate for the treatment of dermatitis of the scalp
by: Ana Cristina Gomes Barros Salgado, et al.
Published: (2010-03-01)

Letter to the editor: indacaterol/glycopyrronium/mometasone furoate compared with salmeterol/fluticasone propionate in patients with asthma: a randomized controlled cross-over study
by: Henrik Watz, et al.
Published: (2020-04-01)

Medication Adherence and Asthma Control with Once-Daily Indacaterol/Glycopyrronium/Mometasone Furoate Breezhaler Digital Companion: 90-Day Analysis from Germany
by: Holger Woehrle, et al.
Published: (2023-04-01)

Cost-Effectiveness of Once-Daily, Single-Inhaler Indacaterol Acetate/ Glycopyrronium Bromide/ Mometasone Furoate in Patients with Uncontrolled Moderate-to-Severe Asthma in Canada
by: Mtibaa M, et al.
Published: (2021-12-01)